RMH Holdings Limited (8437.HK)

HKD 0.17

(-0.58%)

EBITDA Summary of RMH Holdings Limited

  • RMH Holdings Limited's latest annual EBITDA in 2023 was -4.99 Million SGD , up 4.99% from previous year.
  • RMH Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 525.5 Thousand SGD , down 0.0% from previous quarter.
  • RMH Holdings Limited reported an annual EBITDA of -7.83 Million SGD in 2022, up 13.23% from previous year.
  • RMH Holdings Limited reported an annual EBITDA of -2.58 Million SGD in 2021, down -34.48% from previous year.
  • RMH Holdings Limited reported a quarterly EBITDA of 525.5 Thousand SGD for 2024 Q2, down 0.0% from previous quarter.
  • RMH Holdings Limited reported a quarterly EBITDA of -3 Million SGD for 2023 Q1, down -43.98% from previous quarter.

Annual EBITDA Chart of RMH Holdings Limited (2023 - 2015)

Historical Annual EBITDA of RMH Holdings Limited (2023 - 2015)

Year EBITDA EBITDA Growth
2023 -4.99 Million SGD 4.99%
2022 -7.83 Million SGD 13.23%
2021 -2.58 Million SGD -34.48%
2020 -6.47 Million SGD -233.35%
2019 1.82 Million SGD -20.1%
2018 2.28 Million SGD 1839.83%
2017 118 Thousand SGD -96.48%
2016 3.27 Million SGD 13.24%
2015 2.8 Million SGD 0.0%

Peer EBITDA Comparison of RMH Holdings Limited

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD 107.255%
UMP Healthcare Holdings Limited 161.98 Million HKD 103.084%
Human Health Holdings Limited 104.06 Million HKD 104.8%
EuroEyes International Eye Clinic Limited 292.1 Million HKD 101.71%
Kato (Hong Kong) Holdings Limited 133.61 Million HKD 103.738%
Bamboos Health Care Holdings Limited 52.75 Million HKD 109.468%
Beijing Health (Holdings) Limited -44.19 Million HKD 88.697%
C-MER Eye Care Holdings Limited 359.88 Million HKD 101.388%
Town Health International Medical Group Limited 53.5 Million HKD 109.336%
Medicskin Holdings Limited 6.77 Million HKD 173.716%
Hang Chi Holdings Limited 81.58 Million HKD 106.122%